Pharma and BioTech News
Pharma and BioTech Daily
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai , a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
Be sure to visit the podcast's website and support the creator: www.buzzsprout.com
Author
Pharma and BioTech News
Category
Podcast website
Latest episode
Nov 20, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
AstraZeneca's Trixeo EU Approval & Boehringer's $250M Deal | Pharma and Biotech Daily 24.09.2026 5:06
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the dynamic landscape of scientific advances and strategic collaborations shaping patient care and drug development globally. AstraZeneca recently achieved a significant milestone with the European Union's approval of Trixeo, a combination t...
Boehringer Ingelheim's $1B AI Deal & FDA Trials Update | Pharma and Biotech Daily 23.09.2026 5:18
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry is pulsating with advancements, strategic collaborations, regulatory approvals, and promising clinical trial results that are reshaping the landscape of healthcare and drug development. A notable collaboration making waves is between Boehringer Ingelheim...
Telix Buys ITM for $2.35B | Pharma and Biotech Daily 22.09.2026 4:45
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a period of profound transformation within the industry, marked by scientific advancements, strategic acquisitions, and a shifting regulatory landscape that promises to redefine the future of healthcare. Telix Pharmaceuticals has made headlines w...
Ultragenyx’s $4M Fayuvi FDA Approval Breakthrough | Pharma and Biotech Daily 21.09.2026 4:40
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of groundbreaking advancements and strategic shifts shaping the future of this dynamic industry. The FDA has recently approved Ultragenyx's gene therapy, Fayuvi, for a rare neurodegenerative disorder, marking a significant milestone...
Bayer's Kerendia Secures 3rd FDA Approval | Pharma and Biotech Daily 18.09.2026 4:41
Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of pivotal advancements and strategic maneuvers shaping the landscape of drug development and patient care. Bayer's Kerendia, known generically as finerenone, has achieved its third FDA approval, this time targeting chronic...
Novartis Acquires Sironax Platform for $125M | Pharma and Biotech Daily 17.09.2026 4:59
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of dynamic and significant advancements across the industry, from strategic acquisitions to regulatory shifts and scientific innovations. In a bold move, Novartis has acquired Sironax's blood-brain barrier delivery platform...
GSK Acquires Chimagen's Tech for $750M | Pharma and Biotech Daily 16.09.2026 4:53
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant strides and strategic maneuvers reshaping the landscape of healthcare and drug development. Kicking things off, GlaxoSmithKline (GSK) has made headlines with its acquisition of Chimagen Biosciences' trispecific T cell...
Scholar Rock's $20B Pharma Shakeup & More | Pharma and Biotech Daily 15.09.2026 5:10
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today’s episode delves into some of the latest breakthroughs, regulatory updates, and strategic maneuvers reshaping the landscape of drug development and patient care. Starting with remarkable advancements in drug approvals, Scholar Rock's Isembldy (apitegromab)...
Moderna's $1B mRNA Cancer Vaccine Boosts Personalized Meds | Pharma and Biotech Daily 14.09.2026 5:55
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. First, let's delve into the innovative work being done by Grove Biopharma. Founded in 2020 in Chicago, this company is at the forefront of developing polymer-peptide hybrids to target intracellular protein-protein interactions, areas traditionally deemed undrugg...
FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily 11.09.2026 4:55
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the significant advancements and challenges that are shaping the future of drug development, regulatory landscapes, and industry innovations. Starting with a major milestone in personalized cancer therapy, the FDA has expanded Bayer's approv...
Sandoz Invests $2.5B in Biosimilars Network | Pharma and Biotech Daily 10.09.2026 4:42
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Sandoz's recent move to invest $2.5 billion in creating a vertically integrated biosimilar manufacturing network is making waves across the industry. This significant investment underscores the growing importance of biosimilars as cost-effective alternatives to...
AstraZeneca's $116M FDA Win: New Breast Cancer Drug | Pharma and Biotech Daily 09.09.2026 5:06
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we unveil a series of transformative strides in drug approvals, clinical trials, and regulatory landscapes that are reshaping the future of patient care. AstraZeneca's camizestrant, now branded as Etcamah, has received FDA approval for treating ESR1-mutat...
FDA Approves Alzheimer's Drug: Major $ Breakthrough | Pharma and Biotech Daily 08.09.2026 4:38
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In today's episode, we're diving into a series of breakthroughs and significant updates that are shaping the landscape of medicine and treatment. Let's start with a remarkable development in the realm of personalized medicine. Researchers have announce...
Ionis' Zanvastro FDA Approved: $771M Partnership Impact | Pharma and Biotech Daily 07.09.2026 5:14
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of pivotal advances and industry dynamics that are shaping the future of healthcare. The U.S. Food and Drug Administration has recently granted approval to Ionis Pharmaceuticals' Zanvastro, a breakthrough in treating Alexander disea...
Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily 04.09.2026 5:26
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of fascinating updates that are shaping the future of medicine and patient care. First on our agenda is uniQure's ambitious step toward accelerated U.S. marketing approval for AMT-130, a gene therapy targeting Huntington&ap...
AstraZeneca & Roche Secure EU Breast Cancer Approval | Pharma and Biotech Daily 03.09.2026 4:59
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into groundbreaking scientific advancements, crucial regulatory updates, and strategic industry movements that are shaping the future of patient care and drug development. AstraZeneca, in collaboration with Daiichi Sankyo, has achieved a significant m...
Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily 02.09.2026 5:15
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into the dynamic landscape of the industry, highlighting significant scientific breakthroughs, strategic partnerships, and regulatory updates that are reshaping healthcare as we know it. Novartis recently announced a major milestone with its BTK inhibi...
Eli Lilly Acquires Merida for $2.9B | Pharma and Biotech Daily 01.09.2026 4:47
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The current landscape in the pharmaceutical and biotech industries is a tapestry of dynamic mergers, clinical trial advancements, regulatory approvals, and strategic partnerships. A major highlight is Eli Lilly's acquisition of Merida Biosciences for up to $2.9...
Eli Lilly's $173M FDA Win: Mounjaro Approved! | Pharma and Biotech Daily 31.08.2026 5:30
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant advancements and regulatory milestones that underscore the industry's commitment to addressing complex health challenges with innovative therapeutics and strategic investments. Eli Lilly has achieved a major breakthro...
Revolution Medicines' $2.25B FDA Approval Milestone | Pharma and Biotech Daily 28.08.2026 4:53
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore groundbreaking advancements, regulatory updates, and strategic partnerships shaping the future of patient care and drug development. Revolution Medicines has achieved a significant milestone with the FDA approval of its RAS inhibitor, daraxonrasib,...
Revolution Medicines FDA Win: RAS Inhibitor Approved | Pharma and Biotech Daily 27.08.2026 5:13
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Let's dive right into today's top stories, where pioneering advancements and strategic shifts are reshaping how we understand and treat complex diseases. In recent developments, Akeso's PD-1xVEGF bispecific antibody ivonescimab is making waves beyond i...
FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily 26.08.2026 5:14
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the latest happenings in these dynamic sectors, where scientific advancements, regulatory decisions, and strategic business initiatives are continuously reshaping the landscape of healthcare. Starting with a significant regulatory update, the FDA...
Roche & Hanmi's $2.5B Obesity Drug Deal | Pharma and Biotech Daily 25.08.2026 8:38
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In the rapidly evolving landscape of pharmaceutical and biotechnology sectors, several significant developments have marked recent progress in drug development, clinical trials, regulatory approvals, and industry partnerships. A landmark partnership between Roche and...
Roche's $750M Genentech Expansion Boosts Biologics | Pharma and Biotech Daily 24.08.2026 5:35
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the latest strategic moves, regulatory updates, and scientific breakthroughs shaping these dynamic industries. Roche is making headlines with its substantial $750 million investment to expand its Genentech facility in Oregon. This expansion is se...
Ultragenyx's $97M Gene Therapy Breakthrough! | Pharma and Biotech Daily 21.08.2026 5:00
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the latest advancements and achievements across this dynamic industry, where innovation is reaching new heights and regulatory landscapes are continuously evolving. In a groundbreaking moment for gene therapy, Ultragenyx has secu...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.